These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 14681724

  • 1. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F, Zender L, Wirth T, Schulte B, Trautwein C, Manns M, Kubicka S.
    Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
    [Abstract] [Full Text] [Related]

  • 2. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE, Guo ZS, Kagawa S, Gu J, Roth JA, Fang B.
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [Abstract] [Full Text] [Related]

  • 3. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M.
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [Abstract] [Full Text] [Related]

  • 4. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
    Huang D, Desbois A, Hou ST.
    Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
    [Abstract] [Full Text] [Related]

  • 5. Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53.
    Lipinski KS, Djeha AH, Krausz E, Lane DP, Searle PF, Mountain A, Wrighton CJ.
    Gene Ther; 2001 Feb; 8(4):274-81. PubMed ID: 11313801
    [Abstract] [Full Text] [Related]

  • 6. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
    Kraaij R, van der Weel L, de Ridder CM, van der Korput HA, Zweistra JL, van Rijswijk AL, Bangma CH, Trapman J.
    Prostate; 2007 Jun 01; 67(8):829-39. PubMed ID: 17394196
    [Abstract] [Full Text] [Related]

  • 7. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
    Spurgers KB, Coombes KR, Meyn RE, Gold DL, Logothetis CJ, Johnson TJ, McDonnell TJ.
    Oncogene; 2004 Mar 04; 23(9):1712-23. PubMed ID: 14647426
    [Abstract] [Full Text] [Related]

  • 8. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
    Adachi Y, Reynolds PN, Yamamoto M, Grizzle WE, Overturf K, Matsubara S, Muramatsu T, Curiel DT.
    Cancer Res; 2000 Aug 15; 60(16):4305-10. PubMed ID: 10969765
    [Abstract] [Full Text] [Related]

  • 9. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
    Liu BH, Yang Y, Paton JF, Li F, Boulaire J, Kasparov S, Wang S.
    Mol Ther; 2006 Dec 15; 14(6):872-82. PubMed ID: 16904943
    [Abstract] [Full Text] [Related]

  • 10. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 11. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
    Thomas S, Reisman D.
    Cancer Lett; 2006 Aug 18; 240(1):48-59. PubMed ID: 16236433
    [Abstract] [Full Text] [Related]

  • 12. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
    Liu Y, Ye T, Sun D, Maynard J, Deisseroth A.
    Gene Ther; 2006 Aug 18; 13(16):1235-43. PubMed ID: 16617300
    [Abstract] [Full Text] [Related]

  • 13. Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
    Block A, Milasinovic D, Mueller J, Schaefer P, Schaefer H, Greten H.
    Anticancer Res; 2002 Aug 18; 22(6A):3285-92. PubMed ID: 12530077
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
    Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Barker S, Yamaoto M, Li F, Alvarez RD, Curiel DT.
    Cancer Gene Ther; 2004 Apr 18; 11(4):256-62. PubMed ID: 15017380
    [Abstract] [Full Text] [Related]

  • 15. p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model.
    Shirakawa T, Gotoh A, Gardner TA, Kao C, Zhang ZJ, Matsubara S, Wada Y, Hinata N, Fujisawa M, Hanioka K, Matsuo M, Kamidono S.
    J Gene Med; 2000 Apr 18; 2(6):426-32. PubMed ID: 11199263
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun 18; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 17. Targeting gene expression to tumor cells with loss of wild-type p53 function.
    Zhu J, Gao B, Zhao J, Balmain A.
    Cancer Gene Ther; 2000 Jan 18; 7(1):4-12. PubMed ID: 10678350
    [Abstract] [Full Text] [Related]

  • 18. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T, Ohuchida K, Mizumoto K, Onimaru M, Toma H, Nishio S, Nagai E, Matsumoto K, Nakamura T, Tanaka M.
    Clin Cancer Res; 2008 Mar 15; 14(6):1859-67. PubMed ID: 18347189
    [Abstract] [Full Text] [Related]

  • 19. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C.
    Cancer Res; 2009 Sep 01; 69(17):6951-9. PubMed ID: 19690140
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
    Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Yamamoto M, Alvarez RD, Curiel DT.
    Gene Ther; 2004 Apr 01; 11(7):645-8. PubMed ID: 15029227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.